Market Research Logo

Global Bovine Blood Plasma Derivatives Market Report, History and Forecast 2013-2024, Breakdown Data by Manufacturers, Key Regions, Types and Application

Global Bovine Blood Plasma Derivatives Market Report, History and Forecast 2013-2024, Breakdown Data by Manufacturers, Key Regions, Types and Application

The global bovine blood plasma derivatives market is valued at USD 1469 million in 2017 and is expected to reach USD 2289 million by the end of 2024, growing at a Growth Rate of 6.54% between 2017 and 2024.

The major players in global Bovine Blood Plasma Derivatives market include

Thermo Fisher
GE Healthcare
Merck (Sigma-Aldrich)
Moregate BioTech
Gemini
Atlanta Biologicals
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
VWR
Corning
Serana
Lanzhou Minhai
Zhejiang Tianhang Biotechnology
ExCell Bio
Jin Yuan Kang
American Protein Company
Sonac

Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Bovine Blood Plasma Derivatives in these regions, from 2013 to 2024(forecast), covering
North America
Europe
Asia Pacific
South America, Middle East and Africa

On the basis of product, the Bovine Blood Plasma Derivatives market is primarily split into
Bovine Serum
FBS
Bovine Serum Albumin
Fibrinogen
Protein Ingredient
Other

On the basis on the end users/applications, this report covers

Scientific Research
Industrial Production
Feed
Others

The study objectives of this report are:

To study and analyze the global Bovine Blood Plasma Derivatives market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2024.

To understand the structure of Bovine Blood Plasma Derivatives market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To analyze the Bovine Blood Plasma Derivatives with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Bovine Blood Plasma Derivatives submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Bovine Blood Plasma Derivatives are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2024


1 Bovine Blood Plasma Derivatives Market Overview
1.1 Bovine Blood Plasma Derivatives Product Overview
1.2 Bovine Blood Plasma Derivatives Market Segment by Type
1.2.1 Bovine Serum
1.2.2 FBS
1.2.3 Bovine Serum Albumin
1.2.4 Fibrinogen
1.2.5 Protein Ingredient
1.3 Global Bovine Blood Plasma Derivatives by Type
1.3.1 Global Bovine Blood Plasma Derivatives Sales and Growth by Type
1.3.2 Global Bovine Blood Plasma Derivatives Sales Market Share by Type
1.3.3 Global Bovine Blood Plasma Derivatives Revenue Market Share by Type
1.3.4 Global Bovine Blood Plasma Derivatives Price by Type
1.4 North America Bovine Blood Plasma Derivatives by Type
1.5 Europe Bovine Blood Plasma Derivatives by Type
1.6 Asia-Pacific Bovine Blood Plasma Derivatives by Type
1.7 South America, Middle East and Africa Bovine Blood Plasma Derivatives by Type
2 Global Bovine Blood Plasma Derivatives Market Competition by Company
2.1 Global Bovine Blood Plasma Derivatives Revenue and Share by Company (2013-2018)
2.2 Global Top Company Bovine Blood Plasma Derivatives Manufacturing Base Distribution, Product Types
2.3 Bovine Blood Plasma Derivatives Market Competitive Situation and Trends
2.3.1 Bovine Blood Plasma Derivatives Market Concentration Rate
2.3.2 Global Bovine Blood Plasma Derivatives Market Share of Top 3 and Top 5 Company
3 Bovine Blood Plasma Derivatives Company Profiles and Sales Data
3.1 Thermo Fisher
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.1.3 Thermo Fisher Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.1.4 Main Business/Business Overview
3.2 GE Healthcare
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.2.3 GE Healthcare Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.2.4 Main Business/Business Overview
3.3 Merck (Sigma-Aldrich)
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.3.3 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.3.4 Main Business/Business Overview
3.4 Moregate BioTech
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.4.3 Moregate BioTech Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.4.4 Main Business/Business Overview
3.5 Gemini
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.5.3 Gemini Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.5.4 Main Business/Business Overview
3.6 Atlanta Biologicals
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.6.3 Atlanta Biologicals Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.6.4 Main Business/Business Overview
3.7 Tissue Culture Biologicals
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.7.3 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.7.4 Main Business/Business Overview
3.8 Bovogen
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.8.3 Bovogen Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.8.4 Main Business/Business Overview
3.9 Biowest
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.9.3 Biowest Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.9.4 Main Business/Business Overview
3.10 Internegocios
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.10.3 Internegocios Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.10.4 Main Business/Business Overview
3.11 RMBIO
3.11.1 Company Basic Information, Manufacturing Base and Competitors
3.11.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.11.3 RMBIO Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.11.4 Main Business/Business Overview
3.12 Biological Industries
3.12.1 Company Basic Information, Manufacturing Base and Competitors
3.12.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.12.3 Biological Industries Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.12.4 Main Business/Business Overview
3.13 VWR
3.13.1 Company Basic Information, Manufacturing Base and Competitors
3.13.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.13.3 VWR Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.13.4 Main Business/Business Overview
3.14 Corning
3.14.1 Company Basic Information, Manufacturing Base and Competitors
3.14.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.14.3 Corning Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.14.4 Main Business/Business Overview
3.15 Serana
3.15.1 Company Basic Information, Manufacturing Base and Competitors
3.15.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.15.3 Serana Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.15.4 Main Business/Business Overview
3.16 Lanzhou Minhai
3.16.1 Company Basic Information, Manufacturing Base and Competitors
3.16.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.16.3 Lanzhou Minhai Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.16.4 Main Business/Business Overview
3.17 Zhejiang Tianhang Biotechnology
3.17.1 Company Basic Information, Manufacturing Base and Competitors
3.17.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.17.3 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.17.4 Main Business/Business Overview
3.18 ExCell Bio
3.18.1 Company Basic Information, Manufacturing Base and Competitors
3.18.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.18.3 ExCell Bio Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.18.4 Main Business/Business Overview
3.19 Jin Yuan Kang
3.19.1 Company Basic Information, Manufacturing Base and Competitors
3.19.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.19.3 Jin Yuan Kang Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.19.4 Main Business/Business Overview
3.20 American Protein Company
3.20.1 Company Basic Information, Manufacturing Base and Competitors
3.20.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.20.3 American Protein Company Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.20.4 Main Business/Business Overview
3.21 Sonac
3.21.1 Company Basic Information, Manufacturing Base and Competitors
3.21.2 Bovine Blood Plasma Derivatives Product Category, Application and Specification
3.21.3 Sonac Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
3.21.4 Main Business/Business Overview
4 Bovine Blood Plasma Derivatives Status and Outlook by Regions
4.1 Global Bovine Blood Plasma Derivatives Market Status and Outlook by Regions
4.1.1 Global Bovine Blood Plasma Derivatives Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America, Middle East and Africa
4.2 Global Bovine Blood Plasma Derivatives Sales Revenue by Regions
4.2.1 Global Bovine Blood Plasma Derivatives Revenue Market Share by Regions (2013-2018)
4.2.2 Global Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2013-2018)
4.3 North America Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin
4.3.1 North America Bovine Blood Plasma Derivatives Sales Revenue by Countries
4.3.2 United States
4.3.3 Canada
4.3.4 Mexico
4.4 Europe Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2013-2018)
4.4.1 Europe Bovine Blood Plasma Derivatives Sales Revenue by Countries
4.4.2 Germany
4.4.3 UK
4.4.4 France
4.4.5 Italy
4.4.6 Belgium
4.5 Asia-Pacific Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2013-2018)
4.5.1 Asia-Pacific Bovine Blood Plasma Derivatives Sales Revenue by Countries
4.5.2 China
4.5.3 Japan
4.5.4 Korea
4.5.5 Southeast Asia
4.5.6 India
4.6 South America, Middle East and Africa Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2013-2018)
4.6.1 South America, Middle East and Africa Bovine Blood Plasma Derivatives Sales Revenue by Countries
4.6.2 Brazil
4.6.3 Saudi Arabia
4.6.4 Egypt
4.6.5 Nigeria
4.6.6 South Africa
5 Bovine Blood Plasma Derivatives by Application
5.1 Bovine Blood Plasma Derivatives Segment by Application
5.1.1 Scientific Research
5.1.2 Industrial Production
5.1.3 Feed
5.2 Global Bovine Blood Plasma Derivatives Product Segment by Application
5.2.1 Global Bovine Blood Plasma Derivatives Sales by Application
5.2.2 Global Bovine Blood Plasma Derivatives Sales and Market Share by Application (2013-2018)
5.3 North America Bovine Blood Plasma Derivatives by Application
5.4 Europe Bovine Blood Plasma Derivatives by Application
5.5 Asia-Pacific Bovine Blood Plasma Derivatives by Application
5.6 South America, Middle East and Africa Bovine Blood Plasma Derivatives by Application
6 Global Bovine Blood Plasma Derivatives Market Forecast
6.1 Global Bovine Blood Plasma Derivatives Sales Revenue Forecast (2019-2024)
6.2 Global Bovine Blood Plasma Derivatives Forecast by Regions
6.2.1 North America Bovine Blood Plasma Derivatives Sales and Revenue Forecast (2019-2024)
6.2.2 Europe Bovine Blood Plasma Derivatives Sales and Revenue Forecast (2019-2024)
6.2.3 Asia-Pacific Bovine Blood Plasma Derivatives Sales and Revenue Forecast (2019-2024)
6.2.4 South America, Middle East and Africa Bovine Blood Plasma Derivatives Sales and Revenue Forecast (2019-2024)
6.3 Bovine Blood Plasma Derivatives Forecast by Type
6.3.1 Global Bovine Blood Plasma Derivatives Sales Revenue Forecast by Type (2019-2024)
6.3.2 Bovine Serum Growth Forecast
6.3.3 FBS Growth Forecast
6.3.4 Bovine Serum Albumin Growth Forecast
6.3.5 Fibrinogen Growth Forecast
6.3.6 Protein Ingredient Growth Forecast
6.4 Bovine Blood Plasma Derivatives Forecast by Application
6.4.1 Global Bovine Blood Plasma Derivatives Sales Forecast by Application (2019-2024)
6.4.2 Global Bovine Blood Plasma Derivatives Forecast in Scientific Research
6.4.3 Global Bovine Blood Plasma Derivatives Forecast in Industrial Production
6.4.4 Global Bovine Blood Plasma Derivatives Forecast in Feed Production
6.5 Macroscopic Indicator
6.5.1 GDP for Major Regions
6.5.2 Population and Labor Considered for Forecast
6.5.3 Disposable Income Considered for Forecast
7 Bovine Blood Plasma Derivatives Upstream Raw Materials
7.1 Bovine Blood Plasma Derivatives Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 USA Labor Cost Analysis
7.2.4 Europe Labor Costs Analysis
7.2.5 China Labor Costs Analysis
7.2.6 Japan Labor Costs Analysis
7.2.7 Manufacturing Expenses
7.3 Bovine Blood Plasma Derivatives Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Author List
Disclaimer
List of Tables and Figures
Figure Bovine Blood Plasma Derivatives Product Picture
Figure Product Picture of Bovine Serum
Figure Product Picture of FBS
Figure Product Picture of Bovine Serum Albumin
Figure Product Picture of Fibrinogen
Figure Product Picture of Protein Ingredient
Table Global Bovine Blood Plasma Derivatives Sales Revenue (Million USD) and Growth Rate Comparison by Type
Table Global Bovine Blood Plasma Derivatives Sales by Type (2013-2018)
Table Global Bovine Blood Plasma Derivatives Revenue (Million USD) by Type (2013-2018)
Table Global Bovine Blood Plasma Derivatives Revenue Share by Type (2013-2018)
Figure Global Bovine Blood Plasma Derivatives Revenue Share by Type (2013-2018)
Figure 2017 Global Bovine Blood Plasma Derivatives Revenue Market Share by Type
Table Global Bovine Blood Plasma Derivatives Price by Type (2013-2018)
Table North America Bovine Blood Plasma Derivatives Sales by Type (2013-2018)
Table North America Bovine Blood Plasma Derivatives Sales Revenue by Type (2013-2018)
Figure North America Bovine Blood Plasma Derivatives Sales Market by Type (2013-2018)
Table Europe Bovine Blood Plasma Derivatives Sales by Type (2013-2018)
Table Europe Bovine Blood Plasma Derivatives Sales Revenue (Million USD) by Type (2013-2018)
Figure Europe Bovine Blood Plasma Derivatives Sales Market by Type (2013-2018)
Table Asia-Pacific Bovine Blood Plasma Derivatives Sales by Type (2013-2018)
Table Asia-Pacific Bovine Blood Plasma Derivatives Sales Revenue (Million USD) by Type (2013-2018)
Figure Asia-Pacific Bovine Blood Plasma Derivatives Sales Market by Type (2013-2018)
Table South America, Middle East and Africa Bovine Blood Plasma Derivatives Sales by Type (2013-2018)
Table South America, Middle East and Africa Bovine Blood Plasma Derivatives Sales Revenue (Million USD)by Type (2013-2018)
Figure South America, Middle East and Africa Bovine Blood Plasma Derivatives Sales Market by Type (2013-2018)
Table Global Bovine Blood Plasma Derivatives Revenue (Million USD) by Company (2013-2018)
Table Global Bovine Blood Plasma Derivatives Revenue Share by Company (2013-2018)
Figure Global Bovine Blood Plasma Derivatives Revenue Share by Company in 2017
Table Global Bovine Blood Plasma Derivatives Top Company Manufacturing Base Distribution and Sales Area
Table Global Bovine Blood Plasma Derivatives Top Company Product Category
Figure Bovine Blood Plasma Derivatives Market Concentration Rate (Sales Share)
Figure Global Bovine Blood Plasma Derivatives Market Share of Top 3 Company
Figure Global Bovine Blood Plasma Derivatives Market Share of Top 5 Company
Table Thermo Fisher Basic Information List
Table Bovine Blood Plasma Derivatives Picture and Specifications of Thermo Fisher
Table Bovine Blood Plasma Derivatives Picture and Specifications of Life Technologies (Gibco)
Figure Global Manufacturing Sites of Thermo Fisher
Table Picture and Specifications of Newborn Calf Serum (NBCS)
Table Picture and Specifications of Bovine Serum Albumin
Table Thermo Fisher Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
Figure Thermo Fisher Bovine Blood Plasma Derivatives Revenue (Million USD) Growth Rate (2013-2018)
Figure Thermo Fisher Bovine Blood Plasma Derivatives Revenue Global Market Share (%) (2013-2018)
Table GE Healthcare Basic Information List
Table Bovine Blood Plasma Derivatives Picture and Specifications of GE Healthcare
Table Newborn Bovine Serum Picture and Specifications of GE Healthcare
Table Bovine Serum Albumin Picture and Specifications of GE Healthcare
Table GE Healthcare Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
Figure GE Healthcare Bovine Blood Plasma Derivatives Revenue (Million USD) Growth Rate (2013-2018)
Figure GE Healthcare Bovine Blood Plasma Derivatives Revenue Global Market Share (%) (2013-2018)
Table Merck (Sigma-Aldrich) Basic Information List
Table Bovine Blood Plasma Derivatives Picture and Specifications of Merck (Sigma-Aldrich)
Table Bovine Serum Albumin Picture and Specifications of Merck (Sigma-Aldrich)
Table Fibrinogen Picture and Specifications of Merck (Sigma-Aldrich)
Table Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
Figure Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Revenue (Million USD) Growth Rate (2013-2018)
Figure Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Revenue Global Market Share (%) (2013-2018)
Table Moregate BioTech Basic Information List
Table Bovine Blood Plasma Derivatives Picture and Specifications of Moregate BioTech
Table Newborn Bovine Serum Picture and Specifications of Moregate BioTech
Table Bovine Serum Albumin Picture and Specifications of Moregate BioTech
Table Moregate BioTech Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)
Figure Moregate BioTech Bovine Blood Plasma Derivatives Revenue (Million USD) Growth Rate (2013-2018)
Figure Moregate BioTech Bovine Blood Plasma Derivatives Revenue Global Market Share (%) (2013-2018)
Table Gemini Basic Information List
Table Bovine Blood Plasma Derivatives Picture and Specifications of Gemini
Table Newborn Bovine Serum Picture and Specifications of Gemini
Table Bovine Serum Albumin Picture and Specifications of Gemini
Table Gemini Bovine Blood Plasma Derivatives Revenue (Million USD) and Gross Margin (%) (2013-2018)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report